City

Tianjin (1)

Condition

Acute Myeloid Leukemia (1)

CEBPA Double Mutation (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

wang, jianxiang (1)

Collaborator

Intervention

had induction with intermediate dose cytarabine (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

cebpa double mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

CEBPA Double Mutation, Acute Myeloid Leukemia Trial in Tianjin (HAD induction with intermediate dose cytarabine)

Recruiting

CEBPA Double Mutation
Acute Myeloid Leukemia

HAD induction with intermediate dose cytarabine

Tianjin, Tianjin, China

HBDH

Aug 5, 2021